PT  - JOURNAL ARTICLE
AU  - YOTA SHIMODA
AU  - HIROHITO FUJIKAWA
AU  - KEISUKE KOMORI
AU  - HAYATO WATANABE
AU  - KAZUKI KANO
AU  - TAKANOBU YAMADA
AU  - MANABU SHIOZAWA
AU  - SOICHIRO MORINAGA
AU  - KENJI KATSUMATA
AU  - AKIHIKO TSUCHIDA
AU  - TAKASHI OGATA
AU  - TAKASHI OSHIMA
TI  - Prognostic Factors for Gastric Cancer Patients With One Stage IV Factor who Underwent Conversion Surgery
AID  - 10.21873/anticanres.14855
DP  - 2021 Feb 01
TA  - Anticancer Research
PG  - 1005--1012
VI  - 41
IP  - 2
4099  - http://ar.iiarjournals.org/content/41/2/1005.short
4100  - http://ar.iiarjournals.org/content/41/2/1005.full
SO  - Anticancer Res2021 Feb 01; 41
AB  - Background/Aim: To identify prognostic factors for patients with stage IV gastric cancer (GC) and a single stage IV factor before chemotherapy who underwent conversion surgery (R0 resection). Patients and Methods: This study retrospectively analysed 32 GC patients with a single stage IV factor before chemotherapy and who underwent conversion surgery (R0 resection) between January 2001 and September 2015. The univariate and multivariate analyses were performed to identify independent prognostic factors. Results: The five-year survival rate was 39.6%, and the median survival time was 47.0 months. In the univariate analysis, diffuse-type according to Lauren classification was significantly associated with worse overall survival (p<0.001). In the multivariate analysis, diffuse-type was selected as an independent prognostic factor (hazard ratio=15.970, 95% confidence interval=3.804-67.043, p<0.001). Conclusion: Diffuse-type may be a useful prognostic factor in GC patients with a single stage IV factor who undergo conversion surgery (R0 resection).